Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25959631 | 0.91 | SMN1; SMN2 (0.49) | LMNARAB9ANPC1CYP1A2SMN1; SMN2 | |
| SCHEMBL25959681 | 0.91 | RAB9A (0.49) | LMNARAB9ANPC1CYP1A2ALDH1A1 | |
| SCHEMBL25958270 | 0.90 | SMN1; SMN2 (0.51) | LMNARAB9ANPC1CYP1A2SMN1; SMN2 | |
| SCHEMBL25959652 | 0.89 | RAB9A (0.53) | LMNARAB9ANPC1CYP1A2ALDH1A1 | |
| SCHEMBL22257171 | 0.83 | LMNA (0.54) | LMNARAB9ANPC1CYP1A2SMN1; SMN2 | |
| SCHEMBL25959674 | 0.83 | TSHR (0.49) | LMNARAB9ANPC1CYP1A2SMN1; SMN2 | |
| SCHEMBL25959661 | 0.83 | ALOX15 (0.47) | LMNASMN1; SMN2MAPT | |
| SCHEMBL25959684 | 0.83 | RAB9A (0.54) | LMNARAB9ANPC1CYP1A2SMN1; SMN2 | |
| SCHEMBL25959638 | 0.82 | SMN1; SMN2 (0.51) | RAB9ANPC1CYP1A2SMN1; SMN2ALDH1A1 | |
| SCHEMBL25960123 | 0.81 | RAB9A (0.50) | LMNARAB9ANPC1CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248752-A1 | PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME | EMPIRICO INC. | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248752-A1 | PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME | ALOX15, ALOX5, ALOX15B | LMNA 2806/4885RAB9A 4106/4885NPC1 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.